Article
Mutation in the sphingolipid activator protein 2 in a patient with a variant of Gaucher disease.
FEBS letters - 17 Jun 1991
Schnabel D, Schröder M, Sandhoff K
Abstract excerpt
The lysosomal degradation of glucosylceramide requires the hydrolase, glucosylceramide-beta-glucosidase and a sphingolipid activator protein (Gaucher factor, SAP-2, saposin C). Genetic defects in either of these lysosomal proteins cause phenotypically similar disorders in man, the Gaucher disease. SAP-2 originates from a gene which generates a mRNA that codes for four homologous proteins. In a patient with an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
